BUGDF (Bumrungrad Hospital PCL) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


BUGDF Bumrungrad Hospital PCL BUGDF
100 GF Score
Price $4.75
GF Value $5.86
! 1 Warning Sign
View Full Analysis

What is Bumrungrad Hospital PCL Research & Development?

Bumrungrad Hospital PCL BUGDF 100 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.86. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Bumrungrad Hospital PCL's Research & Development for the three months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Bumrungrad Hospital PCL  (OTCPK:BUGDF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bumrungrad Hospital PCL Research & Development Related Terms

Bumrungrad Hospital PCL Research & Development Historical Data

* Premium members only.

The historical data trend for Bumrungrad Hospital PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bumrungrad Hospital PCL Research & Development Chart

Bumrungrad Hospital PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bumrungrad Hospital PCL Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BUGDF
100GF Score
Bumrungrad Hospital PCL BUGDF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bumrungrad Hospital PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Bumrungrad Hospital PCL (BUGDF) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Bumrungrad Hospital PCL and its competitors.
Is Bumrungrad Hospital PCL's Research & Development too high?
Bumrungrad Hospital PCL's current Research & Development is $0.0 Mil. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Research & Development compare to HCA and THC?
Bumrungrad Hospital PCL's Research & Development of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bumrungrad Hospital PCL and its competitors. Bumrungrad Hospital PCL's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Research & Development of $0.0 Mil. The stock's GF Value™ is $5.86, compared to a current price of $4.75 — trading 18.9% below its estimated fair value. The current Research & Development is $0.0 Mil. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued. The current stock price of $4.75 is trading 18.9% below its estimated GF Value™ of $5.86.

Key valuation signals for BUGDF:

  • Research & Development: $0.0 Mil
  • GF Value™: $5.86 vs. price of $4.75 (18.9% below fair value)
  • GF Score™: 100/100 with 1 warning sign

No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bumrungrad Hospital PCL Business Description

Other Exchanges BH:ThailandBZ7A:Germany
Address 33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score

Get the complete analysis for BUGDF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.75
Price
$5.86
GF Value